$22.50
0.894.14%
À la clôture: Nov 13, 4:00 PM EST
$22.06
0.462.13%
Pré-ouverture: 7:00 AM EST

Damora Therapeutics (DMRA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.40 | $-0.45 | 11.1 % |
| Q2 | Aug 10, 2026 | $-0.39 | $-0.37 | -5.41 % |
| Q1 | May 12, 2026 | $-0.62 | $-0.56 | -10.7 % |
| Q4 | Mar 19, 2026 | $2.90 | $-0.12 | 2516.7 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.45 | $-0.37 | $-0.56 | $-0.12 |
| Actual | $-0.40 | $-0.39 | $-0.62 | $2.90 |
| Surprise | +11.1% | -5.41% | -10.7% | +2516.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.47 | $-0.45 | $-0.51 | $-0.52 |
| Revenue | ||||
| Consensus | — | — | — | — |